Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 1294

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 16
Chunk 1294
---

and Liabilities of Discontinued Operations

As
previously described, assets and liabilities of discontinued operations are presented separately in the Consolidated Balance Sheets for
all periods presented. At December 31, 2024 and 2023, these balances consisted of current and long-term assets.

The
following table presents a reconciliation of the carrying amounts of the major classes of these assets and liabilities to the current
and long-term assets and liabilities of discontinued operations as presented on the Company’s Consolidated Balance Sheets:

SCHEDULE
OF DISCONTINUING OPERATIONS BALANCE SHEET AND INCOME STATEMENT

    December
    31, 2024  
    December
    31, 2023 
  
    Assets 

    Current
    Assets 

    Cash and cash
    equivalents 
    $         -  
    $219 
  
    Current
    assets of discontinued operations 
    $-  
    $219 

    Long-term
    Assets 

    Long term assets of
    discontinued operations 
    $-  
    $8,534 

    F-13

Loss
from Discontinued Operations

Discontinued
operations for years ended December 31, 2024 and 2023 consists of results from Graphium Biosciences operations.

The
following table provides details about the major classes of line items constituting “Loss from discontinued operations” presented
on the Company’s Consolidated Statements of Operations:

    December
    31 

    2024  
    2023 

    Operating expenses: 

    Research and
    development 
    $465,936  
    $458,889 
  
    Total operating expenses 
     465,936  
     458,889 

    Loss
    from discontinued operations 
    $(465,936) 
    $(458,889)

3.
ACQUISITION OF COLLINS BUILDING & CONTRACTING

On
August 31, 2023, the Company entered into a stock purchase agreement with the owner of Collins Building & Contracting, Inc. (“Collins
Building”) pursuant to which the owner agreed to sell all of the outstanding common stock of Collins Building to the Company in
exchange for (a) cash consideration of $1,000,000, (b) a five-year secured promissory note in the principal amount of $2,000,000, bearing
interest at 7.0% per annum (the